Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Variations in Kisspeptin Levels During Controlled Ovarian Hyperstimulation in Patients with Polycystic Ovary Syndrome and Their Relationship with Treatment Outcomes

  • By

  • Lu Han

  • Yiran Wang

  • Yueying Li

  • Xiaoyan Li

  • Jing Zhang

  • Yan Zhang

  • Mingfei Zhao

  • Haixia Chen

  • Huiying Zhang

  • Yingmei Wang

  • Fengxia Xue

  • Wenyan Tian

  • May 20, 2026

Share

Clinical Scorecard: Variations in Kisspeptin Levels During Controlled Ovarian Hyperstimulation in Patients with Polycystic Ovary Syndrome and Their Relationship with Treatment Outcomes

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationInfertile women with PCOS undergoing IVF-ET treatment.
Care Setting

Key Highlights

  • Add specific metrics for ovarian response metrics.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor Kisspeptin levels at defined intervals during COH.

      Risks

        Patient & Prescribing Data

        Detail how Kisspeptin levels can guide dosage adjustments.

        Clinical Best Practices

        • Recommend specific assays or methods for evaluating Kisspeptin levels.

        Related Resources & Content

        Original Source(s)

        Related Content